In RAS-driven tumor cells, we have found that MTH1, the mammalian Nudix hydrolase that degrades oxidized purine nucleotides, effectively counteracts the resistance to transformation and malignancy from this inherent oxidative stress. This evidence concerns the gene NUDT1 and neoplasm.